id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-N-4853-0002,FDA,FDA-2017-N-4853,Receipt of Notice That a Patent Infringement Complaint Was Filed Against a Biosimilar Applicant,Notice,General Notice,2017-12-04T05:00:00Z,2017,12,2017-12-04T05:00:00Z,,2017-12-04T15:24:30Z,2017-26013,0,0,0900006482cd3be6
FDA-2017-N-4853-0001,FDA,FDA-2017-N-4853,Receipt of Notice That a Patent Infringement Complaint Was Filed Against a Biosimilar Applicant,Notice,Notice of Publication,2017-11-20T05:00:00Z,2017,11,2017-11-20T05:00:00Z,,2017-11-20T15:07:06Z,2017-25070,0,0,0900006482c91a12